BDSX - Company ID 0001439725
The table below shows BIODESIX INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Revenue | $26.86M | $25.55M | $21.77M | $20.02M | $17.96M | $18.15M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $3.13M | $3.29M | $2.99M | $3.27M | $2.87M | $2.55M |
BIODESIX INC reported annual revenue of $88.50M for fiscal year 2025. That is up 24.1% from $71.32M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $24.55M (FY 2019) to $88.50M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $24.28M |
| $24.26M |
| $21.71M |
| $22.41M |
| $20.45M |
| $20.02M |
| Operating income | -$5.39M | -$6.20M | -$7.05M | -$9.72M | -$9.14M | -$8.59M |
| Income tax | - | $0.00 | - | - | $0.00 | - |
| Net income | -$7.27M | -$7.79M | -$8.72M | -$11.47M | -$11.10M | -$10.26M |
| EPS (diluted) | -$0.71 | -$0.81 | -$1.16 | -$0.08 | -$1.52 | -$1.40 |